Purchases and Sales Made in Q4 2022 in Adial Pharmaceuticals, Inc. (ADIL)
This table provides information about the institutional ownership of Adial Pharmaceuticals, Inc. (ADIL) during Q4 2022. The information is specifically focused on institutions that hold shares of ADIAL PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
108K+ 74.64% |
$21.5K - $996K
|
252K
$254K
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
91KNew |
$18.2K - $842K
|
91K
$91.9K
|
|
|
Feb 10, 2023
Q4 2022
|
Hrt Financial LP
New York, NY |
BUY
|
- |
31.3KNew |
$6.26K - $289K
|
31.3K
$31.6K
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
13.6K+ 76.29% |
$2.72K - $126K
|
31.4K
$31.7K
|
|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
9.71K+ 12.5% |
$1.94K - $89.8K
|
87.4K
$88.3K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
756+ 0.34% |
$151 - $6.99K
|
225K
$227K
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-89- 8.86% |
$17.8 - $823
|
916
$925
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-446- 43.6% |
$89.2 - $4.13K
|
577
$583
|
|
|
Feb 02, 2023
Q4 2022
|
Simplex Trading, LLC
|
SELL
|
- |
-8.6K- 99.51% |
$1.72K - $79.5K
|
42
$42.4
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-13.5K- 37.9% |
$2.69K - $125K
|
22.1K
$22.3K
|
|
|
Feb 09, 2023
Q4 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-56.4K- 99.65% |
$11.3K - $522K
|
200
$202
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-138K- 22.37% |
$27.6K - $1.28M
|
479K
$484K
|